News
Important Only
Golf-Five storylines to follow at this week's U.S. Open
By Frank Pingue OAKMONT, Pennsylvania, June 9 (Reuters) - Five storylines to follow as the world's best players descend upon Oakmont Country Club in Oakmont, Pennsylvania, this week for the June 12-15 U.S. Open.RED-HOT SCHEFFLERScottie Scheffler has three wins in his last four starts on the ...Reuters
Mon, Jun 9
REFILE-Pfizer CEO says 'no commitments' made in meetings with US government on drug pricing
June 9 (Reuters) - Pfizer PFE.N and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but no commitments have been made, Chief Executive Albert Bourla said on Monday at an industry conference.The meetings focused on high-level ideas and were not diggi...Reuters
Mon, Jun 9
Apple faces AI, regulatory challenges as it woos developers at annual conference
AI features delayed, rivals Google and Microsoft advanceRegulatory challenges threaten Apple's App Store feesSmart glasses market sees Meta and Google leadingBy Stephen Nellis CUPERTINO, California, June 9 (Reuters) - Apple is facing an unprecedented set of technical and regulatory challenges...Reuters
Mon, Jun 9
OnePay And Synchrony To Launch New Industry-Leading Credit Card Program With Walmart
June 9 (Reuters) - Synchrony Financial SYF.N:ONEPAY AND SYNCHRONY TO LAUNCH NEW INDUSTRY-LEADING CREDIT CARD PROGRAM WITH WALMART; CREDIT CARD TO BE POWERED BY MASTERCARD AND SET TO GO LIVE THIS FALLReuters
Mon, Jun 9
Slide Insurance launches 20 million share IPO on Nasdaq
June 9 - (The Insurer) - Slide Insurance on Monday announced an initial public offering of 20 million shares which it expects to be priced between $15 and $17 each on the Nasdaq Global Select Market, potentially raising as much as $340 million.Tampa-based Slide, which was founded by Bruce and Shanno...Reuters
Mon, Jun 9
AIG Announces Results And Upsizing Of Its Tender Offers For Certain Outstanding Notes
June 9 (Reuters) - American International Group Inc AIG.N:AIG ANNOUNCES RESULTS AND UPSIZING OF ITS TENDER OFFERS FOR CERTAIN OUTSTANDING NOTESAMERICAN INTERNATIONAL GROUP INC - UPSIZES TENDER OFFERS TO $455 MILLIONReuters
Mon, Jun 9
HUB International Strengthens Wealth Management Services With Acquisition Of Veripax Wealth Management, In California
June 9 (Reuters) - HUB International Ltd [RIC:RIC:HBINT.UL]:HUB INTERNATIONAL STRENGTHENS WEALTH MANAGEMENT SERVICES WITH ACQUISITION OF VERIPAX WEALTH MANAGEMENT, INC. IN CALIFORNIAHUB INTERNATIONAL LTD - TERMS OF HUB-VWM DEAL NOT DISCLOSEDFurther company coverage: HBINT.ULReuters
Mon, Jun 9
Mckesson Says Executives To Meet With Investors And Analysts - SEC Filing
June 9 (Reuters) - Mckesson Corp MCK.N:MCKESSON CORP - EXECUTIVES TO MEET WITH INVESTORS AND ANALYSTS - SEC FILINGMCKESSON CORP - INCREASES FY 2026 ADJUSTED EPS GUIDANCE TO $36.90-$37.70 - SEC FILINGSource text: [ID:n0000927653-25-000045]Reuters
Mon, Jun 9
Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
June 9 (Reuters) - Elevation Oncology Inc ELEV.O:ELEVATION ONCOLOGY ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $0.36 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHTELEVATION ONCOLOGY INC - CONCENTRA TO BUY ELEVATION ONCOLOGY FOR $0.36 PER SHARE PLUS CVRELEVATION ONCOLOGY INC -...Reuters
Mon, Jun 9
Anixa Biosciences Announces Poster Presentation On Ovarian Cancer CAR-T Clinical Trial At ESMO Gynaecological Cancers Congress 2025
June 9 (Reuters) - Anixa Biosciences Inc ANIX.O:ANIXA BIOSCIENCES ANNOUNCES POSTER PRESENTATION ON OVARIAN CANCER CAR-T CLINICAL TRIAL AT THE ESMO GYNAECOLOGICAL CANCERS CONGRESS 2025Reuters
Mon, Jun 9
FDA Removes Partial Clinical Hold On TuHURA Biosciences' Phase 3 Accelerated Approval Trial For IFx-2.0 In Advanced Or Metastatic Merkel Cell Carcinoma
June 9 (Reuters) - TuHURA Biosciences Inc HURA.O:FDA REMOVES PARTIAL CLINICAL HOLD ON TUHURA BIOSCIENCES' PHASE 3 ACCELERATED APPROVAL TRIAL FOR IFX-2.0 IN ADVANCED OR METASTATIC MERKEL CELL CARCINOMAReuters
Mon, Jun 9
DESTINY-Endometrial01 Phase 3 Trial Of ENHERTU® Initiated As First-Line Therapy In Patients With HER2 Expressing Primary Advanced Or Recurrent Endometrial Cancer
June 9 (Reuters) - Daiichi Sankyo Co Ltd 4568.T:DESTINY-ENDOMETRIAL01 PHASE 3 TRIAL OF ENHERTU® INITIATED AS FIRST-LINE THERAPY IN PATIENTS WITH HER2 EXPRESSING PRIMARY ADVANCED OR RECURRENT ENDOMETRIAL CANCERReuters
Mon, Jun 9
Eagle Point Income Company Authorizes $50 Million Stock Repurchase Program
June 9 (Reuters) - Eagle Point Income Company Inc EIC.N:EAGLE POINT INCOME COMPANY INC. ANNOUNCES COMMON STOCK REPURCHASE PROGRAMEAGLE POINT INCOME COMPANY INC - AUTHORIZES $50 MILLION STOCK REPURCHASE PROGRAMReuters
Mon, Jun 9
